本季度信息
先健科技2026年上半年实现营收6.01亿元，同比下降11.2%。毛利为4.66亿元，同比下降6.4%，毛利率由73.6%上升至77.5%。经营亏损为0.11亿元，上年同期为经营利润0.64亿元，同比下降117.5%。经营活动产生的现金净额为3.55亿元，上年同期为3.91亿元，同比下降9.2%。销售及分销开支为1.78亿元，同比减少28.9%；管理费用1.47亿元，同比增加24.3%；研发费用1.32亿元，同比增加15.5%。
业务分项
结构性心脏病业务方面，实现营收2.00亿元，同比下降26.3%，主要由于封堵器产品销售下滑。外周血管病业务营收4.01亿元，同比微增2.3%，在国内及海外市场均有不同程度增长。起搏电生理业务营收13.5百万元，其中主要来自新产品线。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.